Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.
- NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_assertion description "[To scan the human melanoma differentiation antigens TRP-1 and TRP-2 for HLA-DRB1*0301-restricted CD4+ T cell epitopes we applied the following methodology: Splenocytes of HLA-DRB1*0301-transgenic mice immunized with recombinant adenovirus encoding TRP-1 (Ad5.TRP-1) or TRP-2 (Ad5.TRP-2) were tested for their T cell reactivity against combinatorial TRP-1- and TRP-2-specific peptide libraries.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.
- NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_assertion evidence source_evidence_literature NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.
- NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_assertion SIO_000772 21152437 NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.
- NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_assertion wasDerivedFrom befree-2016 NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.
- NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_assertion wasGeneratedBy ECO_0000203 NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.
- befree-2016 importedOn "2016-02-19" NP858711.RADUiZIGFc85SonivvklJ09r3ILaDFVXd1aMhfDygOONU130_provenance.